← Volver atrás
Publicaciones

Incidence and univariate models for lymphatic drainage disorders following management for cervical cancer

Autores

Cea Garcia, Jorge , Rodriguez Jimenez, Inmaculada , Rios-Pena, Laura , Marquez Mareaver, Francisco , Rubio Rodriguez, Maria del Carmen

Publicación externa

No

Medio

J. Obstet. Gynaecol. Res.

Alcance

Article

Naturaleza

Científica

Cuartil JCR

Cuartil SJR

Impacto JCR

1.697

Impacto SJR

0.635

Fecha de publicacion

01/01/2021

ISI

000589395700001

Abstract

Aim To clarify the incidence of lymphatic drainage disorders (LLD) after treatment for cervical cancer (CC) and to establish univariate models for their occurrence. Methods A total of 263 eligible patients with CC were identified between 2010 and 2019. We conducted a case-control study and divided the study population into two subsamples of 12 and 251 CC survivors based on the presence/absence of LLD, respectively. The cumulative incidence was evaluated using the Kaplan-Meier method. Univariate models based on Pearson correlation coefficient were used to evaluate associations between explanatory variables and LLD. Results The cumulative incidence of LLD began at 3.3% after the 7-month follow-up, reaching a plateau of 21.2% between 130 and 250 months of follow-up. We detected correlation between LLD and number of removed para-aortic lymph nodes (r = -0.39), number of pelvic lymphadenopathies (r = 0.16), pelvic lymphadenectomy (PL) (r = 0.16), age at diagnosis of CC (r = -0.1) and primary surgery (r = 0.1). Conclusion We observed a cumulative incidence of LLD of 21.2%, which is in accord with other retrospective studies. Number of removed para-aortic lymph nodes, number of pelvic lymphadenopathies, PL, age at diagnosis of CC and primary surgery were the most influential clinical factors associated with the occurrence of LLD in CC survivors.

Palabras clave

cancer of the cervix; chemotherapy in gynecological cancer; radiation therapy in gynecological cancer; research design; epidemiology and statistics; surgery in gynecological cancer